Evidence map›Paper›PMID 42125357›Full record

ArticleEFSA journal. European Food Safety Authority2014

Scientific Opinion on the safety and efficacy of inositol as a feed additive for fish, dogs and cats.

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Safety and efficacy of inositol as nutritional additive for dogs and cats.EFSA journal. European Food Safety Authority · 2016
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inositol is an essential micronutrient for salmon, carp, tilapia and shrimps, particularly juveniles. This conclusion is extended to all fish and crustaceans. The requirements differ among species and may be in the range of 250-500 mg/kg complete feed for fish. The use of inositol in feed for fish and crustaceans is considered safe at the recommended levels; setting a maximum content is not considered necessary. Based on the study provided in dogs, it was not possible to (i) demonstrate the essentiality of dietary inositol for dogs and (ii) conclude on the safety of dietary inositol at the recommended use levels of between 500 and 3 000 mg/kg. The FEEDAP Panel is not in the position to conclude on the efficacy and safety of inositol for cats. Supplementing feed for fish and crustaceans will not substantially increase the exposure of the consumer to inositol. Considering dietary exposure and endogenous synthesis of inositol, the additional exposure from fish fed an inositol-supplemented diet is of no concern for consumer safety. Considering the potential inhalation exposure upon handling the additive and the absence of data on inhalation toxicity, the FEEDAP Panel concludes that inhalation exposure from handling inositol could be hazardous. In the absence of data, inositol should be considered as irritant to skin and eyes and as a skin sensitiser. Inositol occurs naturally in the environment, particularly in plants. The use of inositol in fish nutrition is not expected to substantially increase the concentration in the environment. Consequently, the supplementation of fish feed with inositol does not pose a risk to the environment.

Indexed as

efficacyinositolnutritional additivesafetyvitamins and provitamins

Identifiers

PMID42125357
PMCPMC13159807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.